Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Monane

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 7, 2014
Enhanced assessment of chest pain and related symptoms in the primary care setting through the use of a novel personalized medicine genomic test: results from a prospective registry studyJoseph A Ladapo, Heather Lyons, May Yau, et al.
Journal of Women'S Health (2002)|January 18, 2019
The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET RegistryBurcu Gul, Alexandra Lansky, Matthew J Budoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
System changes to empower primary care in Alzheimer's disease detection and careSharon Phares, Ian Kremer, J K Wall, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service useStephen J Bartels, Susan D Horn, Randall J Smout, et al.
Journal of the American Heart Association|December 17, 2013
Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery diseaseJoseph A Ladapo, Saul Blecker, Michael R Elashoff, et al.
Journal of Personalized Medicine|October 28, 2025
Implementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center StudyMark Monane, Robert M Carlile, Kim G Johnson, et al.
American Heart Journal|February 23, 2017
An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialDeepak Voora, Adrian Coles, Kerry L Lee, et al.
JAMA|July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary CareSebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Diagnostics (Basel, Switzerland)|January 25, 2025
Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey StudyMark Monane, Demetrius M Maraganore, Robert M Carlile, et al.
Annals of Clinical and Translational Neurology|August 8, 2023
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairmentMark Monane, Kim G Johnson, B Joy Snider, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 7, 2014
Enhanced assessment of chest pain and related symptoms in the primary care setting through the use of a novel personalized medicine genomic test: results from a prospective registry studyJoseph A Ladapo, Heather Lyons, May Yau, et al.
Journal of Women'S Health (2002)|January 18, 2019
The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET RegistryBurcu Gul, Alexandra Lansky, Matthew J Budoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 28, 2026
System changes to empower primary care in Alzheimer's disease detection and careSharon Phares, Ian Kremer, J K Wall, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service useStephen J Bartels, Susan D Horn, Randall J Smout, et al.
Journal of the American Heart Association|December 17, 2013
Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery diseaseJoseph A Ladapo, Saul Blecker, Michael R Elashoff, et al.
Journal of Personalized Medicine|October 28, 2025
Implementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center StudyMark Monane, Robert M Carlile, Kim G Johnson, et al.
American Heart Journal|February 23, 2017
An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialDeepak Voora, Adrian Coles, Kerry L Lee, et al.
JAMA|July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary CareSebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
Diagnostics (Basel, Switzerland)|January 25, 2025
Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey StudyMark Monane, Demetrius M Maraganore, Robert M Carlile, et al.
Annals of Clinical and Translational Neurology|August 8, 2023
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairmentMark Monane, Kim G Johnson, B Joy Snider, et al.
Pageof 3